Jpmorgan Chase & CO Ginkgo Bioworks Holdings, Inc. Transaction History

Jpmorgan Chase & CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.28 - $1.16 $2,827 - $11,713	-10,098 Reduced 1.68%	592,052 $195,000
Q1 2024 May 10, 2024	SELL	$1.06 - $1.67 $496,946 - $782,924	-468,817 Reduced 43.78%	602,150 $698,000
Q4 2023 Feb 12, 2024	BUY	$1.26 - $1.79 $297,768 - $423,019	236,324 Added 28.31%	1,070,967 $1.81 Million
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $89,366 - $140,987	55,507 Added 7.12%	834,643 $1.51 Million
Q2 2023 Aug 11, 2023	SELL	$1.14 - $1.95 $337,740 - $577,714	-296,264 Reduced 27.55%	779,136 $1.45 Million
Q1 2023 May 18, 2023	BUY	$1.2 - $2.19 $679,448 - $1.24 Million	566,207 Added 111.2%	1,075,400 $1.43 Million
Q1 2023 May 11, 2023	SELL	$1.2 - $2.19 $868,873 - $1.59 Million	-724,061 Reduced 58.71%	509,193 $677,000
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $715,134 - $1.54 Million	438,733 Added 55.22%	1,233,254 $2.08 Million
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $184,890 - $947,248	253,275 Added 46.79%	794,521 $2.48 Million
Q2 2022 Aug 11, 2022	SELL	$2.2 - $4.2 $4.74 Million - $9.05 Million	-2,154,882 Reduced 79.93%	541,246 $1.29 Million
Q1 2022 May 11, 2022	BUY	$2.83 - $8.69 $4.24 Million - $13 Million	1,498,987 Added 125.21%	2,696,128 $10.9 Million
Q4 2021 Feb 10, 2022	BUY	$8.31 - $14.92 $9.72 Million - $17.5 Million	1,170,097 Added 4326.64%	1,197,141 $9.95 Million
Q3 2021 Nov 12, 2021	BUY	$9.15 - $13.28 $247,452 - $359,144	27,044 New	27,044 $313,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.